BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 18672301)

  • 1. Covered stents: a review.
    Jamshidi P; Mahmoody K; Erne P
    Int J Cardiol; 2008 Nov; 130(3):310-8. PubMed ID: 18672301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restenosis in percutaneous coronary intervention--is drug-eluting stent the answer?
    Lim VY; Lim YL
    Singapore Med J; 2003 Sep; 44(9):482-7. PubMed ID: 14740779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.
    Newsome LT; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):552-69. PubMed ID: 18633035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis?
    Kumbhani DJ; Bavry AA; Bhatt DL
    Indian Heart J; 2007; 59(2 Suppl B):B113-7. PubMed ID: 19153427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous coronary intervention: historical perspectives, current status, and future directions.
    Arjomand H; Turi ZG; McCormick D; Goldberg S
    Am Heart J; 2003 Nov; 146(5):787-96. PubMed ID: 14597926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer stent coating for prevention of neointimal hyperplasia.
    Billinger M; Buddeberg F; Hubbell JA; Elbert DL; Schaffner T; Mettler D; Windecker S; Meier B; Hess OM
    J Invasive Cardiol; 2006 Sep; 18(9):423-6; discussion 427. PubMed ID: 16954581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.
    Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From randomized trials to routine clinical practice: an evidence-based approach for the use of drug-eluting stents.
    Thanigaraj S; Wollmuth JR; Zajarias A; Chemmalakuzhy J; Lasala JM
    Coron Artery Dis; 2006 Dec; 17(8):673-9. PubMed ID: 17119375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury.
    Scott NA
    Adv Drug Deliv Rev; 2006 Jun; 58(3):358-76. PubMed ID: 16733073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stents: a comprehensive appraisal.
    Butt M; Connolly D; Lip GY
    Future Cardiol; 2009 Mar; 5(2):141-57. PubMed ID: 19371189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of drug-eluting stents: current best available evidence.
    Raja SG; Dreyfus GD
    J Card Surg; 2006; 21(6):605-12; discussion 613-4. PubMed ID: 17073969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very late drug-eluting stent thrombosis and cardiogenic shock: 1,249 days after implantation.
    Chen JP
    J Invasive Cardiol; 2007 Dec; 19(12):E381-4. PubMed ID: 18180534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive stent coatings in the drug-eluting era.
    Menown I; Lowe R; Penn I
    J Invasive Cardiol; 2005 Apr; 17(4):222-8. PubMed ID: 15831978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary stents in the management of coronary artery disease review of first 100 stents.
    Ng SC; Sawatt C; Foo LK; Hitam O; Khor PG; Lee YK
    Med J Malaysia; 1996 Mar; 51(1):75-9. PubMed ID: 10967983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary artery stents: II. Perioperative considerations and management.
    Newsome LT; Weller RS; Gerancher JC; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):570-90. PubMed ID: 18633036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a novel pericardial covered stent to seal an iatrogenic coronary perforation.
    Jokhi PP; McKenzie DB; O'Kane P
    J Invasive Cardiol; 2009 Oct; 21(10):E187-90. PubMed ID: 19805849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of drug-eluting stent and bare-mental stent in the complex small vessel intervention.
    Qiao SB; Hou Q; Xu B; Chen J; Liu HB; Yang YJ; Wu YJ; Yuan JQ; Wu Y; Dai J; You SJ; Zhang P; Gao Z; Dou KF; Qiu H; Mu CW; Li JJ; Chen JL; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):596-600. PubMed ID: 16620702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.